Access to HCV triple therapy with telaprevir or boceprevir in real-life setting in HIV-HCV co-infected patients

Conference Reports for NATAP

IAS 2013: 7th IAS Conference on HIV
Pathogenesis Treatment and Prevention
June 30 - July 3 2013
Kuala Lumpur, Malaysia


Access to HCV triple therapy with telaprevir or boceprevir in real-life setting in HIV-HCV co-infected patients - ANRS CO13 Hepavih Cohort (France)

	Reported by Jules Levin 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, June 30-July 3, 2013, Kuala Lumpur Speaker: Dominique Salmon http://pag.ias2013.org/flash.aspx?pid=76